US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 32.040
  • -0.800-2.44%
Trading Mar 11 09:51 ET
1.79BMarket Cap24.27P/E (TTM)

Supernus Pharmaceuticals Key Stats

Supernus Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 25, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
155.25M
174.16M
+18.91M
Beat Est.
-5.52%
+5.99%
+12.18%
EPS
0
0.27
+0.27
Beat Est.
-100.00%
+1450.57%
--
Buy

Feb 28, 2025

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 154.219M--
--2025/Q1-- / 146.736M--
Feb 25, 20252024/Q4174.159M / 155.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 154.219M--
--2025/Q1-- / 146.736M--
Feb 25, 20252024/Q4174.159M / 155.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--

Unlock Free Earnings Estimates

Supernus Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Buy

  • Buy

    40.00%
  • Hold

    60.00%
  • Sell

    0.00%

Price Target

No Data